A synthetic retinoic acid-inducible gene I (RIG-I) agonist RNA has been shown to induce innate immune signaling and death of hepatocellular carcinoma cells in vitro. The addition of recombinant interferon-b potentiated this cell death, suggesting a potential new mechanism for treating patients with liver cancer.
SourceMary Ann Liebert, Inc./Genetic Engineering News·JournalJournal of Interferon & Cytokine Research·TypeExperimental study·DateFeb 19, 2025
Sodium-glucose cotransporter-2 inhibitors and GLP-1RAs show reduced risk of moderate/severe COPD exacerbations compared to dipeptidyl peptidase 4 inhibitors. This finding may inform glucose-lowering medication prescribing for patients with type 2 diabetes and active COPD.
SourceJAMA Network·JournalJAMA Internal Medicine·DateFeb 10, 2025
SAMSUNG T9 Portable SSD 2TB
SAMSUNG T9 Portable SSD 2TB transfers large imagery and model outputs quickly between field laptops, lab workstations, and secure archives.
Researchers at Tokyo University of Science have found that opioid delta-receptor agonists can alleviate stress-induced IBS symptoms in a validated mouse model by targeting the central nervous system. The study suggests that these drugs could provide a more definitive solution for IBS with minimal adverse effects.
SourceTokyo University of Science·JournalBritish Journal of Pharmacology·TypeExperimental study·DateFeb 5, 2025
A systematic review and network meta-analysis of 601 trials revealed that SGLT2 inhibitors were more cardioprotective in older adults, while GLP-1 receptor agonists offered greater benefits to younger patients. These findings suggest personalized treatment approaches for type 2 diabetes based on age and sex.
A cohort study found that patients without type 2 diabetes had higher discontinuation rates and lower reinitiation rates of GLP-1 receptor agonist therapy. Inequities in access and adherence to effective treatments exacerbate disparities in obesity.
SourceJAMA Network·JournalJAMA Network Open·DateJan 31, 2025
The study found a significant increase in obesity drug prescriptions from 0.76 million in July 2017 to 1.5 million in February 2024, mirroring rising public online search activity for semaglutide and tirzepatide. This correlation highlights the real-time association between public awareness and prescription trends.
SourceJAMA Network·JournalJAMA Network Open·DateJan 29, 2025
A new microdosing approach using low doses of buprenorphine has been tested on patients with opioid use disorder, but most found it ineffective. The study, which included 126 participants, showed that only 34% were able to work up to a full dose of buprenorphine.
SourceUniversity of California - San Francisco·JournalJAMA Network Open·DateJan 24, 2025
Apple iPhone 17 Pro
Apple iPhone 17 Pro delivers top performance and advanced cameras for field documentation, data collection, and secure research communications.
A large population-based analysis found that genetic variants in the GLP1R gene are associated with cardiometabolic traits and behavioral changes, such as risk-taking behavior and anxiety. These findings suggest that any observed behavioral changes with GLP1RA medications are unlikely to be a direct result of the medication.
SourceWiley·JournalDiabetes Obesity and Metabolism·DateJan 22, 2025
Researchers at Nagoya University found that stimulating CB2 with JWH 133 improved cognitive function and reduced neuroinflammation in AD mouse models. The study suggests that CB2 is a potential therapeutic target for Alzheimer's disease, providing a cost-effective alternative to existing treatments.
SourceNagoya University·JournalCell Death and Disease·DateJan 21, 2025
A cohort study found that insurance plan type and structure play a crucial role in determining access to semaglutide for adults with obesity. The findings suggest that targeted interventions at the insurance level could improve equity in obesity treatment access.
SourceJAMA Network·JournalJAMA Network Open·DateJan 21, 2025
A cross-sectional study found that websites selling compounded glucagon-like peptide-1 receptor agonists often misinformed potential consumers about the medications' safety, efficacy, and FDA approval status. The study highlights the need for increased transparency and regulation in the online advertising of these medications.
SourceJAMA Network·JournalJAMA Health Forum·DateJan 17, 2025
A new study reveals that delta opioid receptor agonist KNT-127 has a rapid and effective antidepressant effect with minimal side effects. The research highlights the molecular mechanisms underlying its action, including mTOR signaling pathways and Akt activation in the medial prefrontal cortex.
SourceTokyo University of Science·JournalMolecular Psychiatry·TypeExperimental study·DateJan 14, 2025
Anker Laptop Power Bank 25,000mAh (Triple 100W USB-C)
Anker Laptop Power Bank 25,000mAh (Triple 100W USB-C) keeps Macs, tablets, and meters powered during extended observing runs and remote surveys.
A large international study of GLP1-RA users and dipeptidyl peptidase-4 inhibitors (DPP-4i) found no evidence that GLP1-RA use is associated with an increased risk of thyroid cancer. The study, published in the Thyroid journal, analyzed data from 92,497 GLP1-RA users and 2,484,408 DPP-4i users.
SourceMary Ann Liebert, Inc./Genetic Engineering News·JournalThyroid·TypeObservational study·DateJan 8, 2025
Researchers developed a method to distinguish between similar odours by detecting small electrical changes in olfactory receptors. This innovation enables more precise sensors for industrial applications, such as odour screening.
SourceInstitute for Bioengineering of Catalonia (IBEC)·JournalBiosensors and Bioelectronics·TypeExperimental study·DateDec 20, 2024
Adult obesity trends in the US have declined for the first time in more than a decade, according to recent data. The South region experienced the largest decreases in body mass index and obesity prevalence, despite also facing high COVID-19 mortality rates among obese individuals.
SourceJAMA Network·JournalJAMA Health Forum·DateDec 13, 2024
A cohort study found that nearly half of participants who consumed alcohol at baseline decreased their alcohol use after initiating anti-obesity medication treatment. The medications, such as naltrexone and glucagon-like peptide-1 receptor agonists (GLP-1 RAs), may have properties that lead to reduced cravings for alcohol.
SourceJAMA Network·JournalJAMA Network Open·DateNov 26, 2024
Celestron NexStar 8SE Computerized Telescope
Celestron NexStar 8SE Computerized Telescope combines portable Schmidt-Cassegrain optics with GoTo pointing for outreach nights and field campaigns.
The discontinuation of GLP-1 RAs has significant clinical implications, including reduced glucose control and increased cardiovascular risk. Long-term adherence to these therapies is crucial for optimal patient outcomes.
A phase 2 clinical trial found that the combination of vidutolimod and nivolumab led to tumor control in 55% of patients, with higher levels of immune-related proteins detected in responders. The study also uncovered unique signatures of TLR9 activation and a link between gut microbiome and response to therapy.
SourceUniversity of Pittsburgh·JournalCancer Cell·TypeRandomized controlled/clinical trial·DateNov 1, 2024
A cross-sectional study found a significant increase in GLP-1 receptor agonist (RA) use as anti-obesity medications from 2022 to 2023. Meanwhile, the rate of metabolic bariatric surgery decreased by 25.6% during the same period. These findings suggest a potential shift in treatment strategies for obesity management
SourceJAMA Network·JournalJAMA Network Open·DateOct 25, 2024
The use of GLP-1 receptor agonists (GLP-1RAs) and SGLT2 inhibitors in people with type 1 diabetes has significantly increased between 2010 and 2023. This trend is driven by their benefits in weight management and cardiorenal protection, but caution is advised due to concerns about euglycemic diabetic ketoacidosis.
Two studies found that bariatric surgery is more cost-effective in the long term compared to GLP-1 RA weight loss drugs alone. Combining both treatments is even more cost-effective. The use of GLP-1 RA before surgery appears safe and may be a novel approach to treating obesity.
SourceAmerican College of Surgeons·TypeData/statistical analysis·DateOct 18, 2024
Creality K1 Max 3D Printer
Creality K1 Max 3D Printer rapidly prototypes brackets, adapters, and fixtures for instruments and classroom demonstrations at large build volume.
A new study found that people with opioid or alcohol use disorder who take Ozempic or similar medications have a lower rate of opioid overdose and alcohol intoxication. The medication, which treats diabetes and weight-related conditions, may also alter the brain's reward-response pathways associated with substance use.
SourceSociety for the Study of Addiction·JournalAddiction·TypeObservational study·DateOct 17, 2024
A new study found that GLP1 receptor agonists reduce the risk of suicidal ideation or attempts in adolescents with obesity. The treatment, compared to lifestyle intervention, showed a favorable psychiatric safety profile and potential avenues for future research.
Researchers from Kumamoto University discovered that prostaglandin receptors in the uterus enhance decidualization, a crucial process for successful pregnancy. This finding opens the door to developing new fertility treatments targeting these receptors.
SourceKumamoto University·JournalJournal of Lipid Research·TypeExperimental study·DateSep 17, 2024
A major review by the Cochrane Tobacco Addiction Group identifies three effective ways to stop smoking: counseling, bupropion, and nicotine replacement therapy. The study found that combining these strategies with behavioral support yields the best results for quitting smoking.
SourceUniversity of Massachusetts Amherst·JournalAddiction·TypeLiterature review·DateSep 4, 2024
A cohort study found no association between GLP-1 receptor agonist use and increased risk of suicide death or related disorders in patients with type 2 diabetes. The study included mostly patients with type 2 diabetes.
SourceJAMA Network·JournalJAMA Internal Medicine·DateSep 3, 2024
Kestrel 3000 Pocket Weather Meter
Kestrel 3000 Pocket Weather Meter measures wind, temperature, and humidity in real time for site assessments, aviation checks, and safety briefings.
Researchers have developed a novel nanoparticle drug-delivery system to activate an immune pathway in combination with tumor-targeting agents, showing promising results in treating pancreatic cancer. Eight out of nine mice tested experienced tumor improvements, including two complete responses.
SourceUniversity of Massachusetts Amherst·JournalScience Translational Medicine·TypeExperimental study·DateAug 28, 2024
A North Carolina State University study found that only 12% of organizations providing residential opioid substance use services are licensed by the state. Only a quarter allow patients to access proven opioid agonist treatment (OAT), which has better outcomes and cuts overdose deaths in half.
SourceNorth Carolina State University·JournalJournal of Substance Use and Addiction Treatment·TypeSurvey·DateAug 28, 2024
A new study found that semaglutide significantly reduces major adverse cardiac events, including heart attacks and strokes, among overweight individuals with cardiovascular disease. The medication also shows similar benefits for people with pre-existing heart failure, regardless of type or severity.
SourceUniversity College London·JournalThe Lancet·TypeRandomized controlled/clinical trial·DateAug 22, 2024
Sky-Watcher EQ6-R Pro Equatorial Mount
Sky-Watcher EQ6-R Pro Equatorial Mount provides precise tracking capacity for deep-sky imaging rigs during long astrophotography sessions.
Researchers found GLP-1 receptor agonists lower risks of certain obesity-associated cancers in patients with type 2 diabetes, suggesting potential benefits for cancer prevention in high-risk populations. The study provides preliminary evidence supporting further preclinical and clinical studies to prevent specific obesity-linked cancers.
SourceJAMA Network·JournalJAMA Network Open·DateJul 5, 2024
A study published in JAMA Ophthalmology found an association between semaglutide and nonarteritic anterior ischemic optic neuropathy, a condition that can cause vision loss. The observational study suggests caution when prescribing semaglutide to patients at risk of this condition.
SourceJAMA Network·JournalJAMA Ophthalmology·DateJul 3, 2024
A randomized clinical trial found that combining exercise with glucagon-like peptide-1 receptor agonist (GLP-1RA) treatment was the most effective weight loss strategy while preserving bone health. In contrast, GLP-1RA treatment alone reduced bone mineral density at clinically relevant sites.
SourceJAMA Network·JournalJAMA Network Open·DateJun 25, 2024
GoPro HERO13 Black
GoPro HERO13 Black records stabilized 5.3K video for instrument deployments, field notes, and outreach, even in harsh weather and underwater conditions.
In individuals with a diabetes duration of 10 years or less, bariatric metabolic surgery was associated with greater weight loss and reduced mortality compared to first-generation GLP-1RAs. No differences were observed between treatment modalities in patients with longer diabetes duration.
SourceJAMA Network·JournalJAMA Network Open·DateJun 7, 2024
The study found a substantial increase in glucagon-like peptide-1 receptor agonist (GLP-1RA) dispensing among adolescents and young adults between 2020 and 2023. This trend is particularly notable for females, emphasizing the need for targeted education on sex-specific safety risks, such as concerns during pregnancy.
A novel combination of two existing drugs has been discovered to eradicate AML cancer cells in lab-based tests, offering hope for patients diagnosed annually with the disease. The treatment, pairing venetoclax with a STING agonist, showed high promise in AML samples driven by a mutated p53 protein, a type of AML generally harder to treat.
SourceWalter and Eliza Hall Institute·JournalCancer Cell·TypeObservational study·DateApr 30, 2024
A recent study found that preoperative GLP-1 receptor agonist use is not associated with an increased risk of postoperative respiratory complications. The results suggest liberalizing withholding guidelines for these medications may be beneficial.
Fluke 87V Industrial Digital Multimeter
Fluke 87V Industrial Digital Multimeter is a trusted meter for precise measurements during instrument integration, repairs, and field diagnostics.
A new study estimates that opioid dependence in Scotland has remained relatively stable since 2014/15, affecting 1.3% of the adult population aged 15-64. The prevalence of opioid dependence among those aged 50-64 increased by 2,800, while those aged 15-34 decreased by 5,100.
SourceUniversity of Bristol·JournalAddiction·TypeObservational study·DateApr 17, 2024
A study published in JAMA Surgery found that 56% of patients using GLP-1 RAs had significant gastric contents on ultrasound before elective procedures, despite adequate fasting. The study suggests that conventional fasting times may need to be reexamined for this patient subset.
SourceUniversity of Texas Health Science Center at Houston·JournalJAMA Surgery·TypeObservational study·DateMar 6, 2024
Research has shown that dulaglutide, a diabetes drug, can reduce depressive-like behaviors in mice. The study identified four major pathways involved and linked markers of depression to lipid metabolism and tryptophan metabolism. This new perspective may facilitate the use of dulaglutide as a potential therapeutic strategy for depression.
Aranet4 Home CO2 Monitor
Aranet4 Home CO2 Monitor tracks ventilation quality in labs, classrooms, and conference rooms with long battery life and clear e-ink readouts.
A new study published in the American Heart Association journal Hypertension found that tirzepatide significantly lowered systolic blood pressure levels in nearly 500 adults with obesity. The results suggest treating obesity with this weight loss medication may be an effective strategy for preventing or treating high blood pressure.
SourceAmerican Heart Association·JournalHypertension·DateFeb 5, 2024
Only 4.1% of hospital encounters for opioid overdoses led to opioid agonist therapy (OAT) initiation within a week of discharge from hospital, highlighting missed opportunities to prevent future mortality and morbidity related to opioid use disorder. Studies show that prompt OAT initiation in the emergency department is crucial to redu...
SourceCanadian Medical Association Journal·JournalCanadian Medical Association Journal·TypeObservational study·DateDec 18, 2023
A Northwestern University study found that nearly two-thirds of patients discontinue or change their medication within a year, highlighting the need for better understanding of barriers to treatment adherence. The high discontinuation rate for GLP-1 RAs may be due to gastrointestinal side effects.
SourceNorthwestern University·JournalThe American Journal of Managed Care·DateDec 12, 2023
A large study of 91,460 mother-offspring pairs found no link between prenatal corticosteroid and beta-2 adrenergic agonist exposure and offspring neurodevelopmental issues. The findings suggest these medications are safe for pregnant individuals with asthma.
SourceJAMA Network·JournalJAMA Network Open·DateOct 24, 2023
Researchers at UC Irvine issue a warning that GLP-1RA's may be dangerous for children due to the risk of nutrient imbalance and abuse. The team notes that children need energy and sufficient calories for growth and development, and any change in their diet and exercise balance can have long-term health consequences.
SourceUniversity of California - Irvine·JournalClinical and Translational Science·TypeData/statistical analysis·DateAug 28, 2023
Sony Alpha a7 IV (Body Only)
Sony Alpha a7 IV (Body Only) delivers reliable low-light performance and rugged build for astrophotography, lab documentation, and field expeditions.
The study reveals the molecular mechanism by which ABCC4 recognizes broad-spectrum substrates, providing a structural basis for rational design of platelet antagonists targeting ABCC4. The research also elucidated the molecular mechanism of ABCC4 in binding and transporting platelet agonists and antagonists.
SourceUniversity of Science and Technology of China·JournalNature Cardiovascular Research·DateJul 28, 2023
A new study found that higher doses of oral semaglutide improved regulation of blood sugar levels and weight loss compared to lower doses. Participants who received the 25mg and 50mg doses lost an average of 17.5 pounds, nearly twice as much weight loss as those who took the lowest dose.
SourceUniversity of North Carolina Health Care·JournalThe Lancet·DateJun 26, 2023
Researchers discuss the potential of glucocorticoid-induced TNFR-related protein (GITR) as a target for cancer immunotherapy. Preclinical studies have shown potent anti-tumor efficacy, but clinical trials have yielded inconsistent results due to complexities in immune responses and antibody structure.
SourceImpact Journals LLC·JournalOncotarget·TypeCommentary/editorial·DateJun 21, 2023
A recent Finnish register-based study found no association between inhaled beta-2 agonist use and reduced risk of Parkinson's disease. Accumulation of alpha-synuclein protein is a key factor in the disease. The study controlled for age, sex, and comorbidities to rule out confounding factors.
SourceUniversity of Eastern Finland·JournalClinical Epidemiology·DateJun 14, 2023
Researchers at Kanazawa University used high-speed atomic force microscopy to study the TRPV1 protein's structural fluctuations in response to stimulating and suppressing ligands. They found that ligand binding increases conformational fluctuations, while suppression decreases them.
SourceKanazawa University·JournalProceedings of the National Academy of Sciences·DateMay 14, 2023
Apple AirPods Pro (2nd Generation, USB-C)
Apple AirPods Pro (2nd Generation, USB-C) provide clear calls and strong noise reduction for interviews, conferences, and noisy field environments.
KNT-127 exhibits anti-stressing and anti-depressant effects in mice, improving social interaction and reducing stress-induced hormone levels. The agent suppresses neuronal inflammation and newborn death without affecting neurogenesis.
SourceTokyo University of Science·JournalNeuropharmacology·TypeExperimental study·DateMay 8, 2023
Researchers at Temple University and Johns Hopkins University found that brain-derived neurotrophic factor (BDNF) loss underlies post-myocardial infarction heart failure. BDNF levels can be replenished therapeutically, abolishing damage to heart tissue and enabling recovery.
SourceTemple University Health System·JournalCirculation Research·DateMar 30, 2023
Researchers at Moffitt Cancer Center have discovered a combination strategy that targets the STING signaling pathway, resulting in improved antitumor activity. Inhibiting methylation increases STING expression and activates immune cells, leading to enhanced antitumor immunity.
SourceH. Lee Moffitt Cancer Center & Research Institute·JournalNature Communications·TypeExperimental study·DateMar 27, 2023
A study found that over 80% of American adults with type 2 diabetes meet the criteria to use GLP-1 RAs or SGLT2is, but only a small percentage are using them. The medications have a substantially higher cost than current first-line treatments, making it difficult for patients to access them.
SourceAmerican College of Physicians·JournalAnnals of Internal Medicine·TypeData/statistical analysis·DateFeb 27, 2023
GQ GMC-500Plus Geiger Counter
GQ GMC-500Plus Geiger Counter logs beta, gamma, and X-ray levels for environmental monitoring, training labs, and safety demonstrations.
A recent study found that adults with type 1 diabetes are at a high risk of being overweight or obese, but only half receive lifestyle recommendations to manage their weight. The study also highlighted the importance of individualized patient education in improving weight management for these patients.
SourceAmerican College of Physicians·JournalAnnals of Internal Medicine·TypeData/statistical analysis·DateFeb 13, 2023
Researchers from UTSA and UT Health San Antonio are developing compounds that target the estrogen receptor-beta, which suppresses cancer growth. The goal is to identify a novel ER-beta agonist with potential as a therapeutic strategy for treating GBM in patients.
A new preclinical study discovered the underlying cause of gender differences in immunotherapy-associated myocarditis and identified potential treatment strategies. Hormone therapies targeting the endocrine-cardiac-immune pathway may reduce this risk without affecting treatment efficacy.
SourceUniversity of Texas M. D. Anderson Cancer Center·JournalScience Translational Medicine·DateNov 2, 2022
A new approach combines an immunotherapy agent with a molecular delivery system that targets tumor acidity, successfully eradicating colorectal tumors in mice. The researchers believe this method may increase the effectiveness of STING agonist therapy for cancer patients.
SourceUniversity of Rhode Island·JournalFrontiers in Oncology·DateOct 18, 2022
A cross-sectional study of over 70,000 Asian Americans found significant variation in obesity prevalence among subgroups, with Filipino Americans having the highest rate at 28.7% and Chinese Americans the lowest at 13.2%. The study highlights the need for tailored strategies to address obesity disparities among Asian American populations.
SourceAmerican College of Physicians·JournalAnnals of Internal Medicine·TypeData/statistical analysis·DateOct 3, 2022
DJI Air 3 (RC-N2)
DJI Air 3 (RC-N2) captures 4K mapping passes and environmental surveys with dual cameras, long flight time, and omnidirectional obstacle sensing.
Lenabasum has been shown to improve skin symptoms in patients with amyopathic dermatomyositis, demonstrating significant reductions in inflammation and disease severity. The study's findings suggest that lenabasum is a well-tolerated treatment option for refractory skin disease.
SourceElsevier·JournalJournal of Investigative Dermatology·TypeRandomized controlled/clinical trial·DateSep 21, 2022
Researchers have combined tesaglitazar and GLP-1 in a new hormone combination for type 2 diabetes treatment, improving glucose metabolism with minimal doses. The new drug has shown promise in animal studies, reducing kidney damage and increasing insulin sensitivity.
SourceDeutsches Zentrum fuer Diabetesforschung DZD·JournalNature Metabolism·TypeExperimental study·DateAug 26, 2022